Alecta claims more than EUR 134m from Novo Nordisk, which has been charged with financial market manipulation
The Swedish pension fund claims more than EUR 134m in compensation from Novo Nordisk, making it responsible for the single largest claim in the Danish legal case against the company charged with financial market manipulation.

BY KEVIN GRØNNEMANN, MEDWATCH
One Swedish pension fund stands out in the sizeable crowd of investors claiming compensation from Novo Nordisk in a Danish legal case of financial market manipulation.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app